Tamsulosin Hydrochloride

盐酸坦洛新

Report date: 2026/03/23 20:03:44

Base Information

Drug NameTamsulosin Hydrochloride
Drug Alias Name盐酸坦索罗辛Tamsulosin Hydrochloride盐酸坦舒洛辛Amsulosin Hydrochloride坦索罗辛 +[30] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1a adrenergic receptor antagonists
TargetsAlpha-1a adrenergic receptor
Therapy Area/IndicationsLower Urinary Tract SymptomsUrological ManifestationsPain +[13] 
Global Approved IndicationsProstatic Hyperplasia
Approved Indications in ChinaProstatic Hyperplasia
Original Approved Country/TerritoryJapan
Original Approved Date1993/01/01
Country/TerritoryBelgiumArmeniaCanada +[21] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesDexa Medica GroupQingdao Baheal Medical IncLawson Health Research Institute +[10] 
Inactive CompaniesHanmi Pharmaceutical Co LtdYamanouchiGl Pharm Tech Co +[17] 
Active IndicationsHernia, InguinalUrinary RetentionProstatic Hyperplasia +[4] 
Inactive IndicationsLower Urinary Tract SymptomsUrological ManifestationsPain +[9] 

Other Information

ATC CodeG04CA02
Related LinksWikipediaDrugBankKEGG